Molander, Pauliina <br/><br/>
Long-term outcome of inflammatory bowel disease patients with deep remission after discontinuation of TNFα-blocking agents.  [electronic resource] 

 -  Scandinavian journal of gastroenterology  Mar 2017 
 - 284-290 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1502-7708 
<br/><br/><label>Standard No.: </label>10.1080/00365521.2016.1250942  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--therapeutic use<br/>Adolescent<br/>Adult<br/>Child<br/>Female<br/>Finland<br/>Follow-Up Studies<br/>Humans<br/>Inflammatory Bowel Diseases--classification<br/>Infliximab--therapeutic use<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Proportional Hazards Models<br/>Recurrence<br/>Remission Induction<br/>Retrospective Studies<br/>Risk Factors<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Young Adult